Cubist Systematic Strategies, LLC Aclaris Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 6,971 shares of ACRS stock, worth $27,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,971

Previous 44,783 84.43%

Holding current value

$27,605

Previous $49,000 85.71%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.12 - $1.4 $42,349 - $52,936	-37,812 Reduced 84.43%	6,971 $7,000
Q2 2024 Aug 14, 2024	SELL	$1.01 - $1.36 $120 - $161	-119 Reduced 0.27%	44,783 $49,000
Q1 2024 May 15, 2024	SELL	$0.92 - $1.44 $83,161 - $130,165	-90,393 Reduced 66.81%	44,902 $55,000
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $59,053 - $598,838	92,271 Added 214.46%	135,295 $142,000
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $104,284 - $174,072	-15,897 Reduced 26.98%	43,024 $294,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $31,133 - $41,985	3,946 Added 7.18%	58,921 $611,000
Q1 2023 May 15, 2023	BUY	$7.07 - $17.95 $388,673 - $986,801	54,975 New	54,975 $444,000
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $12,298 - $17,145	-941 Reduced 10.4%	8,109 $128,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $57,109 - $96,006	5,621 Added 163.93%	9,050 $126,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $171,258 - $315,087	-17,583 Reduced 83.68%	3,429 $59,000
Q4 2021 Feb 14, 2022	BUY	$12.27 - $18.49 $24,687 - $37,201	2,012 Added 10.59%	21,012 $306,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $458,358 - $644,031	-34,257 Reduced 64.32%	19,000 $342,000
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $186,940 - $323,972	-10,945 Reduced 17.05%	53,257 $935,000
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $376,223 - $1.78 Million	64,202 New	64,202 $1.62 Million
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $10,743 - $20,750	-10,533 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $395 - $1,235	-500 Reduced 4.53%	10,533 $11,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $21,544 - $71,411	-10,115 Reduced 47.83%	11,033 $24,000
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $365,465 - $508,925	-64,914 Reduced 75.43%	21,148 $127,000
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $542,190 - $1.33 Million	86,062 New	86,062 $636,000
Q2 2018 Aug 14, 2018	SELL	$16.46 - $20.33 $137,622 - $169,979	-8,361 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $119,713 - $179,710	7,009 Added 518.42%	8,361 $146,000
Q4 2017 Feb 14, 2018	SELL	$21.47 - $27.8 $89,422 - $115,787	-4,165 Reduced 75.49%	1,352 $33,000
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $127,001 - $158,889	5,517	5,517 $142,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $264M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Aclaris Therapeutics, Inc. Transaction History